Virtue 340B

06/16/2026

Discussions about 340B program growth often focus on a single metric: total 340B purchases.

But what if that number only tells part of the story?

As conversations around the future of the 340B Program continue, it's worth asking a broader question:

What factors are actually contributing to the growth we're seeing?

Healthcare inflation. Specialty drug utilization. Expansion of outpatient care. Hospital consolidation. Growing patient demand for complex therapies.

These trends are reshaping healthcare delivery nationwide, yet they're often missing from discussions about 340B growth.

In our latest article, we explore several important considerations that provide additional context for understanding the data and why simple narratives may overlook the realities facing hospitals and health systems today.

If you're involved in 340B oversight, compliance, pharmacy leadership, or healthcare finance, this discussion is worth following.

Read the full article here:
🔗 https://virtue340b.com/340b-growth-in-context-what-the-data-shows/

Learn the key factors behind 340B program growth and what the data actually reveals.

06/11/2026

If your organization were asked today to explain how it oversees its 340B program, could leadership clearly answer the question?

Not just whether the program is compliant.

But where risk exists.

What controls are in place.

How oversight decisions are documented.

And whether those decisions would remain defensible months—or years—from now.

These are the questions independent audits are designed to answer.

The strongest 340B programs aren't necessarily the ones with the fewest findings.

They're the ones that understand their risks, maintain visibility into their operations, and continuously strengthen oversight.

At Virtue 340B®, our independent audits help healthcare organizations move beyond compliance checklists and gain meaningful insight into program risk, governance, and operational durability.

Explore our Independent 340B Audit Services:
🔗 https://virtue340b.com/independent-340b-audits/

Prepare for HRSA oversight with a comprehensive independent 340B audit. Identify compliance gaps, strengthen policies, and protect your program.

06/01/2026

Final reminder — our upcoming webinar with 𝗛𝗔𝗡𝗬𝗦 𝗠𝗮𝗿𝗸𝗲𝘁𝗽𝗹𝗮𝗰𝗲 is just 48 hours away!

As 340B complexity continues to increase, many organizations are asking the same questions:

Do we have clear visibility into how our program is operating?
Are our eligibility and documentation approaches truly defensible?
Where could risk be quietly accumulating?

Join 𝗩𝗶𝗿𝘁𝘂𝗲 𝟯𝟰𝟬𝗕 on 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆, 𝗝𝘂𝗻𝗲 𝟯, at 𝟭𝟮 𝗣𝗠 𝗘𝗧 for:

𝗖𝗼𝗻𝘁𝗿𝗼𝗹𝗹𝗶𝗻𝗴 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗖𝗮𝗻 𝗶𝗻 𝗮 𝟯𝟰𝟬𝗕 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁: 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗢𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁, 𝗩𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆, 𝗮𝗻𝗱 𝗗𝗲𝗳𝗲𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆

We’ll discuss practical approaches to strengthening program oversight, improving visibility into potential exposure areas, and navigating evolving expectations surrounding eligibility, duplicate discounts, and recertification.

If you are involved in 340B oversight, compliance, pharmacy operations, finance, or audit readiness, we’d love to have you join the conversation.

🔗 Registration Link: https://my.hanys.org/Events/Calendar-Of-Events/Meeting-Home-Page?meetingid=%7b7fbc4d11-3538-f111-88b4-6045bd01524d%7d

05/25/2026

Today, we pause to remember and honor the courageous individuals who gave their lives in service to our nation.

Wishing everyone a meaningful and reflective Memorial Day from the Virtue 340B team.

05/20/2026

As the 340B landscape continues to evolve, organizations are facing increasing pressure to strengthen oversight, improve documentation, and maintain confidence in how their programs are being managed.

In partnership with HANYS Marketplace, Virtue 340B will be hosting an upcoming webinar:

𝗖𝗼𝗻𝘁𝗿𝗼𝗹𝗹𝗶𝗻𝗴 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂 𝗖𝗮𝗻 𝗶𝗻 𝗮 𝟯𝟰𝟬𝗕 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁: 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝗶𝗻𝗴 𝗢𝘃𝗲𝗿𝘀𝗶𝗴𝗵𝘁, 𝗩𝗶𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆, 𝗮𝗻𝗱 𝗗𝗲𝗳𝗲𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆
📅 Wednesday, June 3
🕛 12:00 PM ET

This discussion will focus on practical strategies that organizations can use to improve visibility into their 340B programs, strengthen internal controls, and address eligibility, duplicate-discount risk, and recertification with greater clarity and defensibility.

Topics will include:
• Patient eligibility and qualifying prescription considerations
• Offsite department and documentation methodologies
• Duplicate discount risk and emerging exposure areas
• Recertification as a meaningful oversight checkpoint

This session is designed for pharmacy leadership, compliance professionals, finance leaders, and executive stakeholders responsible for 340B oversight.

🔗 Registration Link: https://my.hanys.org/Events/Calendar-Of-Events/Meeting-Home-Page?meetingid=%7b7fbc4d11-3538-f111-88b4-6045bd01524d%7d

05/13/2026

How often does your organization talk about its 340B program—and is that message consistent?

Telling your 340B story isn’t just something to revisit during audits or external pressure. It’s an ongoing effort that helps build credibility, align teams, and clearly communicate the value your program brings to patients and the community.

In this episode, Katy Lees breaks down how to approach that communication more effectively—from internal alignment to explaining social ROI and real-world program impact.

If you’re looking to bring more clarity and consistency to how your 340B program is understood, this conversation is a strong starting point.

Visit Virtue 340B’s website to watch or listen on your preferred platform. https://virtue340b.com/content-hub/katys-340b-compass/

Watch Katy Lees, 340B ACE-certified advisor, break down complex compliance topics with practical guidance you can apply to your program today.

04/30/2026

Running a 340B program today is more complex than ever.

For many organizations, the challenge isn’t just compliance—it’s understanding where risk may be building over time and whether current processes will hold up if questions arise later.

That’s where Virtue 340B comes in.

We provide independent, objective oversight to help healthcare organizations:
✔ Identify potential areas of exposure
✔ Strengthen program oversight
✔ Build confidence in day-to-day operations

We don’t manage programs or sell software; our focus is on helping you see clearly and move forward with confidence.

If your team has questions or is looking for a fresh perspective, we’d be glad to connect.

Learn more:
https://virtue340b.com/homepage/

Independent 340B compliance advisory — audits, monitoring, and education for covered entities. See how we help you stay audit-ready year-round.

04/27/2026

What actually defines a 340B “patient”?

It’s a simple question—but right now, it’s at the center of a major legal challenge.

In this episode of Katy’s 340B Compass, Katy Lees explains how AbbVie v. HHS is putting long-standing assumptions under pressure, while recent court rulings are also clarifying the limits of HRSA’s authority.

The result? More attention on how organizations define patient eligibility—and how well they can support those decisions.

You’ll learn:
• Why the patient definition is being challenged
• What this could mean for audits and oversight
• How to think about defensibility in today’s environment

Visit Virtue 340B’s website to watch or listen to the full episode on your preferred platform. https://virtue340b.com/content-hub/katys-340b-compass/

Watch Katy Lees, 340B ACE-certified advisor, break down complex compliance topics with practical guidance you can apply to your program today.

04/22/2026

Have a question about your 340B program?

Katy is inviting members of the 340B community to share what’s on their mind through 𝗞𝗮𝘁𝘆’𝘀 𝟯𝟰𝟬𝗕 𝗖𝗼𝗺𝗽𝗮𝘀𝘀. Whether you’re working through a specific challenge or just looking for clarity in a complex area, this is a great way to get insight.

She’s especially interested in addressing the most relevant and pressing topics organizations are facing right now, and your question could be featured in an upcoming episode.

Submit your question here:
https://virtue340b.com/content-hub/katys-340b-compass/

We look forward to hearing what’s on your mind!

Watch Katy Lees, 340B ACE-certified advisor, break down complex compliance topics with practical guidance you can apply to your program today.

04/14/2026

There’s a lot of conversation right now about the recent 340B GPO court ruling—but what does it actually mean for your day-to-day operations?

While the decision may open the door to new approaches for initial inventory purchasing, it doesn’t change the core compliance rules. Hospitals still need to follow strict replenishment processes, and the GPO prohibition remains in place.

In this episode, Katy Lees walks through what’s changed, what hasn’t, and where organizations need to stay especially careful to avoid compliance risk.

Visit Virtue 340B’s website to watch or listen to the full episode on your preferred platform.
https://virtue340b.com/content-hub/katys-340b-compass/

Watch Katy Lees, 340B ACE-certified advisor, break down complex compliance topics with practical guidance you can apply to your program today.